<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Amlodipine, lisinopril, chlorthalidone, and rates of heart failure (HF) in hypertensive patients</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Amlodipine, lisinopril, chlorthalidone, and rates of heart failure (HF) in hypertensive patients</h1>
<div class="graphic"><div class="figure"><div class="ttl">Amlodipine, lisinopril, chlorthalidone, and rates of heart failure (HF) in hypertensive patients</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">In the ALLHAT trial, cumulative event rates for the development of heart failure (HF) according to primary treatment with chlorthalidone, amlodipine, or lisinopril. Compared to chlorthalidone, there were significant increases in the six year rate of HF with both amlodipine (10.2 versus 7.7 percent, relative risk 1.38, 95 percent CI 1.25 to 1.52) and lisinopril (8.7 versus 7.7 percent, relative risk 1.19 95 percent CI 1.07 to 1.31).</div><div class="graphic_reference">Data from The ALLHAT Officers, JAMA 2002; 288:2981.</div><div id="graphicVersion">Graphic 68780 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
